Antibodies to SARS-CoV-2 were tested in children aged 1 to 18 years living in Bavaria, Germany, participating in a public health type 1 diabetes screening program, the Fr1da study.
Antibodies testing was performed in capillary blood using LIPS assays. Antibody positivity was defined as dual-positive response against both the receptor binding domain and the nucleocapsid protein of SARS-CoV-2.
With the currently selected data filters there are:
SARS-CoV-2 antibody prevalence by month in children living in Bavaria
SARS-CoV-2 antibody prevalence by region in children living in Bavaria
Follow-up of 99 children with positive SARS-CoV-2 antibodies over time
Click on one sample to highlight all related samples.
Double-click on an empty space to deselect all.